Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > NN-Labs Receives $2 million in SBIR Contracts

NN-Labs Receives $2 million in SBIR Contracts

Fayetteville, AR | Posted on October 17, 2006

­NN-Labs, LLC (Nanomaterials and Nanofabrication Laboratories), an Arkansas based nanotechnology firm, was recently awarded three Small Business Innovation Research (SBIR) contracts. The awards consist of two Phase II contracts, from the National Institutes of Health (NIH) and the National Science Foundation (NSF), and one Phase I contract from NIH; all three contracts total $1.8 million. Work on these new projects is already underway.

The funds will aid in NN-Labs’ ability to extend its strength in nanocrystals into end products in the biomedical field. Currently, cadmium containing semiconductor nanocrystals constitute all of the company’s standardized product lines for semiconductor nanocrystals, also known as quantum dots. While non-cadmium containing nanomaterials, such as gold nanoparticles and iron oxide (Fe3O4) magnetic Nanoparticles, are available through custom orders, the product lines are not yet complete or standardized.

The NIH Phase II, entitled Kits for Converting Nanocrystals to Standard Bio-Medical Reagents, Second Generation Nanocrystal Bio-Medical Labels follows the success of the Phase I that focused on the development of bio-medical labels based on the first generation of semiconductor nanocrystals, CdSe quantum dots. NN-Labs will develop the second generation of quantum dots, which are doped zinc containing semiconductor nanocrystals (d-dots). D-dots will ultimately remove heavy metal cadmium from the current workhorse—cadmium selenide related nanocrystals—of quantum dots. In addition, d-dots are also more durable and have better optical properties when high density emitters are needed. It is expected that these new fluorescence labels will make early diagnosis of various diseases and pathogens more practical and less expensive.

Commercial Scale Production of High Quality and Affordable Fe3O4 Nanocrystals for Nano-Biomedicine is the title of the NSF Phase II contract that will expand upon the product line developed in the Phase I contract. The biomedical applications for these Fe3O4 magnetic nanocrystals cover many aspects of the biomedical field, ranging from diagnostics, detection, therapy, separation, and pollution control, etc, which is at least a multi-billion-dollar market. Yet another variety of nanocrystal is to be developed with funding from the NIH Phase I contract, entitled High Yield and Inexpensive Production of High Quality Gold Nanocrystals as Bio-Labels. Similar to the other contracts, the end goal is to enhance already existing biomedical techniques as well as open the door to novel applications in the biomedical field. NN-Labs strives to complete this Phase I as successfully as we have for other Phase I awards, which will help us to secure the corresponding Phase II award from NIH with additional funding of $750K for two years.

NN-Labs has been business active for about four years, since July of 2002. The company has received 15 SBIR contracts (about $5m in total) that have partially funded the development of four standardized product lines, with several other product lines that are still under development and in the trial sales stage. The company maintains affiliations with the University of Arkansas and the Arkansas Science and Technology Authority (ASTA). NN-Labs is also a member of the Genesis Technology Incubator. Additional information about NN-Labs can be found on the company’s website, www.nn-labs.com, or by contacting Leah Sheridan at 479-575-2723 or lmbulla@nn-labs.com.

####

Contact:
Leah Sheridan
479-575-2723
lmbulla@nn-labs.com

Copyright © NN-Labs, LLC

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Nanometrics to Participate in the 6th Annual NYC Investor Summit 2017 November 16th, 2017

180 Degree Capital Corp. Leads Investment in TheStreet, Inc.; Investment Enables Removal of Capital Structure Overhang November 14th, 2017

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) October 23rd, 2017

Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM(TM) Platform and Lead RNAi-based Drug Candidates September 14th, 2017

Nanomedicine

Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3’s significant potential role in Immuno-Oncology at SITC Annual Meeting November 14th, 2017

Arrowhead to Present at 29th Annual Piper Jaffray Healthcare Conference November 14th, 2017

A new way to mix oil and water: Condensation-based method developed at MIT could create stable nanoscale emulsions November 8th, 2017

Nanoshells could deliver more chemo with fewer side effects: In vitro study verifies method for remotely triggering release of cancer drugs November 8th, 2017

Materials/Metamaterials

ICN2 researchers compute unprecedented values for spin lifetime anisotropy in graphene November 17th, 2017

Math gets real in strong, lightweight structures: Rice University researchers use 3-D printers to turn century-old theory into complex schwarzites November 16th, 2017

A new way to mix oil and water: Condensation-based method developed at MIT could create stable nanoscale emulsions November 8th, 2017

TUBALL nanotube-based concentrates recognised as the most innovative raw material for composites by JEC Group November 7th, 2017

Announcements

ICN2 researchers compute unprecedented values for spin lifetime anisotropy in graphene November 17th, 2017

Math gets real in strong, lightweight structures: Rice University researchers use 3-D printers to turn century-old theory into complex schwarzites November 16th, 2017

The stacked color sensor: True colors meet minimization November 16th, 2017

Nanometrics to Participate in the 6th Annual NYC Investor Summit 2017 November 16th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project